98%
921
2 minutes
20
Rapid expansion of nanotechnology and indiscriminate discharge of metal oxide nanoparticles (NPs) into the environment pose a serious hazard to the ecological receptors including plants. To better understand the role of miRNAs in ZnO-NPs stress adaptation, two small RNA libraries were prepared from control and ZnO-NPs (800 ppm, <50 nm particle size) stressed maize leaves. Meager performance of ZnO-NPs treated seedlings was associated with elevated tissue zinc accumulation, enhanced ROS generation, loss of root cell viability, increased foliar MDA content, decrease in chlorophyll and carotenoids contents. Deep sequencing identified 3 (2 known and 1 novel) up- and 77 (73 known and 4 novel) down-regulated miRNAs from ZnO-NPs challenged leaves. GO analysis reveals that potential targets of ZnO-NPs responsive miRNAs regulate diverse biological processes viz. plant growth and development (miR159f-3p, zma_18), ROS homeostasis (miR156b, miR166l), heavy metal transport and detoxification (miR444a, miR167c-3p), photosynthesis (miR171b) etc. Up-regulation of SCARECROW 6 in ZnO-NPs treated leaves might be responsible for suppression of chlorophyll biosynthesis leading to yellowing of leaves. miR156b.1 mediated up-regulation of CALLOSE SYNTHASE also does not give much protection against ZnO-NPs treatment. Taken together, the findings shed light on the miRNA-guided stress regulatory networks involved in plant adaptive responses to ZnO-NPs stress.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chemosphere.2020.126197 | DOI Listing |
Anticancer Agents Med Chem
August 2025
Department of Health Information Management, College of Applied Medical Sciences, Buraydah Private Colleges, Buraydah 51418, Saudi Arabia.
Introduction: Chemotherapy faces limitations such as toxicity and resistance, necessitating novel cancer treatments. Green-synthesized zinc oxide nanoparticles (ZnO-NPs) have attracted attention for their safety, biocompatibility, and therapeutic potential. This study investigates the anticancer efficacy of ZnO-NPs synthesized using the extracellular matrix of Aspergillus biplanus against colorectal cancer cell lines (HCT-116).
View Article and Find Full Text PDFTissue Cell
August 2025
Pharmacology Department, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt. Electronic address:
The present novel trial assesses the prophylactic influence of ZnO NPs in comparison to silymarin against liver damage induced by acetaminophen (APAP). Forty albino rats were allocated into 4 groups (n = `10 rats/ group). Group I (Control), was orally administered 0.
View Article and Find Full Text PDFMetab Brain Dis
September 2025
Technology of Medical Laboratory Department, Faculty of Technology of Applied Health Sciences, October 6 University, Giza, 3230911, Egypt.
Widespread use of Zinc Oxide Nanoparticles (ZnO NPs) raises concerns about potential health risks, particularly following maternal exposure during critical developmental windows. The impact of exposure on offspring brain development remains unclear. The work aims to investigate the neurodevelopmental consequences of maternal ZnO NP exposure during gestation, lactation, or both periods in male rat offspring.
View Article and Find Full Text PDFJ Biochem Mol Toxicol
September 2025
Environmental Health and Toxicology Laboratory, Department of Environmental Sciences, School of Life Sciences, Bharathiar University, Coimbatore, Tamil Nadu, India.
The release of synthesized zinc oxide nanoparticles (ZnO-NPs) into the environment and consequent human exposure risk brought enormous attention in recent years. In recent decades, a range of toxicological effects were highlighted on hepatotoxic risk during ZnO-NPs exposure without precise mechanistic verification. The current study employed proteomic profiling (LC-MS/MS) to unveil the interaction of ZnO-NPs with human serum proteins (protein corona) and its relevant hepatotoxic mechanisms.
View Article and Find Full Text PDFDrug Dev Ind Pharm
September 2025
Department of Pharmaceutics, Allana College of Pharmacy, Pune, Maharashtra, India.
This study aims to develop and evaluate the wound-healing and anti-inflammatory potential of Ash-ZnO NPs and Ash-ZnO NPs gel formulation, synthesized using extract and stabilized in a chitosan matrix. The goal was to overcome the limitations of conventional ZnO nanoparticles, including instability, cytotoxicity, and uncontrolled release. Although ZnO nanoparticles possess antimicrobial and regenerative properties, their clinical utility is limited by aggregation and dose-dependent toxicity.
View Article and Find Full Text PDF